Lipid Management
The latest information on HDL and LDL cholesterol, metabolic syndrome, statins, triglycerides, and more, drawn from across our primary care and specialty care areas. Sign up now for monthly e-mail alerts on new content.
SUMMARY AND COMMENT
What Is the Best Approach to Lipid Management?
- January 27, 2010
- Joel M. Gore, MD
- Cardiology
In a simulation study, basing statin treatment on overall cardiovascular risk produced better outcomes than basing treatment on target LDL levels.
- Reviewing:
- Hayward RA et al. Ann Intern Med 2010 Jan 19; 152:69
SUMMARY AND COMMENT
High-Dose Statins Before Percutaneous Coronary Intervention
- January 13, 2010
- Howard C. Herrmann, MD
- Cardiology
In statin-naive patients, a single loading dose of atorvastatin within 24 hours before PCI significantly reduced the rate of periprocedural MI.
- Reviewing:
- Briguori C et al. J Am Coll Cardiol 2009 Dec 1; 54:2157
SUMMARY AND COMMENT
Perimenopausal Changes in Cardiac Risk Factors
- January 12, 2010
- Kirsten E. Fleischmann, MD, MPH
- General Medicine
Lipid levels are particularly sensitive to the menopausal transition.
- Reviewing:
- Matthews KA et al. J Am Coll Cardiol 2009 Dec 15/22; 54:2366
SUMMARY AND COMMENT
Reducing Blood Pressure Levels Effectively in Practice
- January 6, 2010
- Frederick A. Masoudi, MD, MSPH
- Cardiology
Two interventions each helped to modify this cardiovascular risk factor successfully, but staffing such programs would be costly.
- Reviewing:
- Ma J et al. Arch Intern Med 2009 Nov 23; 169:1988
SUMMARY AND COMMENT
Epidemiology of Hyperlipidemia in the U.S.Free
- December 17, 2009
- Thomas L. Schwenk, MD
- General Medicine
The high prevalence of untreated hyperlipidemia in high-risk patients requires new approaches. Interview CME
- Reviewing:
- Kuklina EV et al. JAMA 2009 Nov 18; 302:2104
SUMMARY AND COMMENT
Diabetes, Depression, and Disease Control
- December 7, 2009
- Joel Yager, MD
- Psychiatry
In patients with diabetes, depression is associated with reduced compliance with medical treatments and worse disease control.
- Reviewing:
- Katon W et al. Psychosom Med 2009 Nov/Dec; 71:965
SUMMARY AND COMMENT
Women and Heart Disease: More Work to Be Done
- December 3, 2009
- JoAnne M. Foody, MD
- Women's Health
In recent years, in-hospital MI mortality has improved but MI incidence has risen.
- Reviewing:
- Towfighi A et al. Arch Intern Med 2009 Oct 26; 169:1762
SUMMARY AND COMMENT
Lipids, Apolipoproteins, and Vascular Disease: What to Measure?
- November 24, 2009
- Thomas L. Schwenk, MD
- General Medicine
Either total and HDL cholesterol, or apolipoproteins, fasting or not, are equally accurate. CME
- Reviewing:
- Di Angelantonio E et al. for the Emerging Risk Factors Collaboration. JAMA 2009 Nov 11; 302:1993
SUMMARY AND COMMENT
Lipid-Lowering Therapy in HIV-Infected Patients
- November 18, 2009
- Rajesh T. Gandhi, MD
- Infectious Diseases
Gemfibrozil levels are reduced by lopinavir/ritonavir coadministration, which may explain the difficulty in lowering triglycerides in HIV-infected patients.
- Reviewing:
- Busse KH et al. J Acquir Immune Defic Syndr 2009 Oct 1; 52:235
SUMMARY AND COMMENT
Rosuvastatin Beats Pravastatin for PI-Associated Hyperlipidemia
- November 16, 2009
- Abigail Zuger, MD
- HIV/AIDS Clinical Care
However, the study was small, and patients were followed for only 45 days.
- Reviewing:
- Aslangul E et al. AIDS 2009 Oct 15
